Trial on the efficacy of propranolol on the progression of varices in patients with cirrhosis
Not Applicable
Terminated
- Conditions
- Oesophageal varices
- Registration Number
- SLCTR/2007/001
- Lead Sponsor
- Faculty of Medicine, University of Kelaniya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- Not specified
- Target Recruitment
- 210
Inclusion Criteria
Patients with clinical, biochemical, radiological features of cirrhosis confirmed wherever possible by histology 18 -70 years of age Patients with no varices or small varices (less than 5mm) No history of upper GI bleeding Patients not on any vasoactive medications
Exclusion Criteria
•Patients who do not fulfill inclusion criteria •Patients currently on primary prophylaxis •Patients with severe obesity •Patients with oesophageal varices more than 5mm •Patients with gastric varices •Patients with contraindications for beta blockers •Patients with hepatocellular carcinoma •Patients with portal vein thrombosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Enlargemert of varices beyond 5mm <br>Bleeding from oesophageal varices [2 years]<br>
- Secondary Outcome Measures
Name Time Method one [None]<br>